logo
Plus   Neg
Share
Email

Medtronic Plc Q4 Profit Beats Estimates - Quick Facts

Medtronic plc (MDT) said its fourth-quarter non-GAAP net income and non-GAAP diluted EPS were up 7 percent and 8 percent, respectively, from previous year. Adjusting for negative impact from foreign currency, fourth-quarter non-GAAP diluted EPS increased 9 percent. Revenue grew 3.6% organic, for the quarter. Looking forward, for fiscal 2020, Medtronic projects revenue growth to approximate 4.0 percent on an organic basis.

For the fourth-quarter, non-GAAP earnings per share was $1.54 compared to $1.42 previous year. On average, 25 analysts polled by Thomson Reuters expected the company to report profit per share of $1.47 for the quarter. Analysts' estimates typically exclude special items.

Fourth-quarter revenue was $8.1 billion, flat as reported. Analysts expected revenue of $8.11 billion, for the quarter.

For fiscal 2020, the company expects non-GAAP EPS in the range of $5.44 to $5.50, including an estimated 10 cent negative impact from foreign exchange based on current rates. Analysts expect the company to report profit per share of $5.44.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway reported a profit for the second-quarter that increased 87 percent from last year, as the value of its investment portfolio increased with the stock market. But it took about $10 billion write down on the value of its Precision Castparts aircraft parts unit due to the impact of the COVID-19 pandemic. Operating profit declined 10 percent. Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients.
Follow RTT